Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 14:28:100409.
doi: 10.1016/j.ensci.2022.100409. eCollection 2022 Sep.

The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a

Hanne van Ballegooijen  1 , Karin van der Hiele  2 , Christian Enzinger  3 , Gert de Voer  4 , Leo H Visser  5 ; CONFIDENCE Study Group
Affiliations

The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a

Hanne van Ballegooijen et al. eNeurologicalSci. .

Erratum in

Abstract

Background: Cognitive dysfunction is common in multiple sclerosis and may worsen with reduced treatment adherence. We examined longitudinal relationships between anxiety, depression, fatigue, disability and adherence with cognitive status in patients with relapsing-remitting multiple sclerosis (MS) treated with interferon beta-1a in four countries.

Methods: The Confidence study is a prospective study in 165 people with MS with four visits (baseline/12/24/36 months). Physical and psychological symptoms were assessed using standardized questionnaires. Adherence was calculated as the number of injections divided by number of expected injections. Cognitive status was assessed by the Brief Repeatable Battery of Neuropsychological Tests and converted to a global Z-score.

Results: At baseline, mean age was 35.7 ± 11 years and 66% were female (n = 109). Adherence to treatment was very high throughout the study (>99%). A depression score ≥ 8 was significantly associated with a higher risk of low cognitive status compared with a lower score (0-7): relative risk 1.79 (1.14-2.83) adjusted for education and time since diagnosis. The P-value-for-time was not significant (P = 0.304) meaning that associations existed since baseline and remained stable during follow-up.

Conclusion: Our findings provide evidence for a longitudinal association between depression and low cognitive status in patients treated with interferon beta-1a in routine medical practice.

Keywords: Adherence; Anxiety; Cognitive status; Depression; Disability; Fatigue; Interferon beta-1a; Multiple sclerosis.

PubMed Disclaimer

Figures

Unlabelled Image
Graphical abstract
Fig. 1
Fig. 1
Flow diagram of Confidence Study patients. Visit 1: 12 months; visit 2: 24 months; visit 3: 36 months.
See this image and copyright information in PMC

References

    1. Rao S.M., et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41(5):685–691. - PubMed
    1. Amato M.P., Zipoli V., Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J. Neurol. Sci. 2006;245(1–2):41–46. - PubMed
    1. Glanz B.I., et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult. Scler. 2007;13(8):1004–1010. - PubMed
    1. Charvet L.E., et al. Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial. PLoS One. 2017;12(5) - PMC - PubMed
    1. Broicher S.D., et al. Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years. J. Neurol. 2018;265(5):1016–1025. - PubMed

LinkOut - more resources